FDA Inspection 1211253 — Albhades Provence

Albhades Provence — FEI 3006218344

The FDA completed an inspection of Albhades Provence on June 21, 2023 in Oraison. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 21, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Oraison (France)